Telo Therapeutics

Public

Baltimore, MarylandBiotechhttps://www.telotherapeutics.com

Telo Therapeutics is now publicly traded

The data on this page reflects Telo Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series A

Dec 21, 2022

Total Funding Raised

$4.71M

Company Overview

Telo Therapeutics is a biotechnology company focused on developing cancer therapeutics aimed at enhancing survival and quality of life for patients with limited treatment options.

Sector

Biotech

AI Layer

Non-AI

Keywords

small molecule telomerase modulatorstelomerase reverse transcriptase (TERT) activatorstelomerase reverse transcriptase (TERT) inhibitorsproprietary small molecule discovery platformtelomere biology drug discoverytherapeutics for pulmonary fibrosistherapeutics for bone marrow failurepreclinical oncology therapeuticstherapeutics for age-related diseasesbiotech drug candidate out-licensingpreclinical biotechnology company

Telo Therapeutics Comparables

Compare Telo Therapeutics with similar companies based on industry and business-model similarity.

Telo Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Rejuvenation Technologies	57%

View all Comparables

Telo Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 21, 2022
Seed	Jun 21, 2022

View all Funding Rounds

Telo Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Telo Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBaltimore, Maryland

Employee Range2

Year Founded2015

Last FundingDec 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?